Deccan Health Care Stock Screener | Share Price & Fundamental Analysis
DECCAN
Healthcare Service Provider
Screen Deccan Health Care share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹14.76
▼
-0.72 (-4.65%)
Market Cap
₹37.50 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.34
EPS (TTM)
₹0.54
Dividend Yield
-
Debt to Equity
0.01
52W High
₹30.00
52W Low
₹14.51
Operating Margin
8.00%
Profit Margin
4.76%
Revenue (TTM)
₹21.00
EBITDA
₹2.00
Net Income
₹1.00
Total Assets
₹125.00
Total Equity
₹106.00
Deccan Health Care Share Price History - Stock Screener Chart
Screen DECCAN historical share price movements with interactive charts. Analyze price trends and patterns.
Deccan Health Care Company Profile - Fundamental Screener
Screen Deccan Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DECCAN shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE452W01019
Deccan Health Care Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen DECCAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 125 | 108 | 97 | 91 | 92 |
| Current Assets | 106 | 88 | 76 | 68 | 67 |
| Fixed Assets | 14 | 16 | 17 | 19 | 20 |
| Liabilities | |||||
| Total Liabilities | 125 | 108 | 97 | 91 | 92 |
| Current Liabilities | 3 | 4 | 4 | 3 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 106 | 97 | 82 | 77 | 77 |
| Share Capital | 23 | 20 | 17 | 16 | 16 |
| Reserves & Surplus | 82 | 75 | 65 | 61 | 61 |
Screen DECCAN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21 | 22 | 21 | 20 | 19 | 15 | 16 | 15 | 17 | 11 | 16 | 9 | 12 | 9 |
| Expenses | 20 | 21 | 20 | 20 | 18 | 14 | 15 | 14 | 16 | 10 | 15 | 9 | 11 | 8 |
| EBITDA | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Operating Profit % | 8.00% | 3.00% | 3.00% | 3.00% | 6.00% | 6.00% | 4.00% | 8.00% | 6.00% | 7.00% | 5.00% | -2.00% | 7.00% | 7.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | -1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | -1 | 0 | 0 |
| EPS | 0.37 | 0.10 | 0.05 | 0.07 | 0.26 | 0.18 | 0.06 | 0.29 | 0.32 | 0.18 | 0.16 | -0.27 | 0.17 | 0.13 |
Deccan Health Care Cash Flow Screener - Liquidity Fundamentals
Screen DECCAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | -6 | -13 | -7 | -1 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 8 | 14 | 5 | 0 | 0 |
| Net Cash Flow | 1 | 1 | -1 | -1 | 0 |
Screen DECCAN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Oct | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 19.46% | 18.42% | 18.42% | 16.12% | 16.12% | 15.66% | 18.95% | 18.26% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 5.68% | 5.37% | 5.37% | 6.53% | 6.53% | 6.34% | 6.09% | 5.87% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 47.83% | 46.53% | 46.40% | 52.31% | 50.78% | 49.44% | 47.51% | 48.92% |
| Other Holding | 27.03% | 29.68% | 29.81% | 25.05% | 26.57% | 28.57% | 27.45% | 26.95% |
| Shareholder Count | 3,614 | 3,667 | 3,743 | 2,737 | 3,002 | 3,154 | 3,154 | 3,416 |
Deccan Health Care Dividend Screener - Share Yield Analysis
Screen DECCAN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Deccan Health Care Index Membership - Market Screener Classification
Screen DECCAN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Deccan Health Care Market Events Screener - Corporate Actions
Screen DECCAN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 3.44% | ||
| Annual General Meeting | NA | -5.82% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -3.95% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -6.94% |
| 2025-07-09 | 2025-07-09 | Extraordinary General Meeting | NA | 0.89% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 1.46% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -11.49% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 3.23% |
Deccan Health Care Competitors Screener - Peer Comparison
Screen DECCAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,700 | 46.83 | 2,555 | 11.28% | 492 | 51.43 |
| Vijaya Diagnostic Centre | 10,881 | 70.34 | 700 | 23.06% | 144 | 61.34 |
| Metropolis Healthcare | 10,019 | 61.96 | 1,346 | 10.64% | 146 | 53.04 |
| Thyrocare Technologies | 7,309 | 56.28 | 702 | 20.80% | 91 | 53.15 |
| Nephrocare Health Services | 4,760 | 68.04 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,379 | 28.37 | 743 | 16.70% | 78 | 46.09 |
| Suraksha Diagnostic | 1,441 | 45.66 | 256 | 15.11% | 31 | 45.86 |
| One Global Service Provider | 1,237 | 28.65 | 148 | 134.60% | 19 | 58.56 |
| 3B BlackBio DX | 1,214 | 24.67 | 112 | 28.72% | 48 | 56.43 |
| Sastasundar Ventures | 1,004 | -103.51 | 1,171 | -18.47% | -134 | 60.55 |
Deccan Health Care Company Announcements - News Screener
Screen DECCAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Closure of Trading Window | View |
| 2025-12-11 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E 11Th December 2025 | View |
| 2025-12-08 | Board Meeting Intimation for Appointment Of Independent Directors | View |
| 2025-12-04 | Disclosure under Regulation 30A of LODR | View |
| 2025-12-03 | Disclosure under Regulation 30A of LODR | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-14 | Approval Of Unaudited Financial Results For Quarter Ended Sep-25 | View |
| 2025-11-14 | Board Meeting Outcome for Out Of Board Meeting For Approval Of Financial Results For Quarter Ended 30Th September 2025 | View |
| 2025-11-10 | Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results (Standalone & Consolidated) Along With The Limited Review Report Thereon For The Half Year Ended 30 September 2025. | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | E Voting Results AGM | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-28 | Reg. 34 (1) Annual Report. | View |
| 2025-09-25 | Closure of Trading Window | View |